A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 263
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MRP1
Long Form : multidrug resistance protein 1
No. Year Title Co-occurring Abbreviation
2019 A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity. ABC, FACS
2019 Chemo-sensitizing activity of natural cadinanes from Heterotheca inuloides in human uterine sarcoma cells and their in silico interaction with ABC transporters. BCRP
2019 Cloning, expression of the truncation of recombinant peroxidase derived from millet bran and its reversal effects on 5-Fu resistance in colorectal cancer. BCRP, P-gp, pMal-s
2019 Exposure of Cultured Astrocytes to Menadione Triggers Rapid Radical Formation, Glutathione Oxidation and Mrp1-Mediated Export of Glutathione Disulfide. ROS
2019 LINC00511 knockdown prevents cervical cancer cell proliferation and reduces resistance to paclitaxel. CC, lncRNA, MMP, P-gp, PTX
2019 LncRNA BLACAT1 is involved in chemoresistance of non‑small cell lung cancer cells by regulating autophagy. ATG7, BLACAT1, LC3, lncRNA, miR, NSCLC
2019 Lung clearance of inhaled aerosol of Tc-99m-methoxyisobutyl isonitrile: relationships with cigarette smoking, age and gender. Tc-99m-MIBI
2019 Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. FSIP1
2019 Structure-guided probing of the leukotriene C4 binding site in human multidrug resistance protein 1 (MRP1; ABCC1). hMRP1, LTC4
10  2019 The reversal of MRP1 expression induced by low-frequency and low-intensity ultrasound and curcumin mediated by VEGF in brain glioma. LFLIU, VEGF
11  2018 An Outward-Facing Aromatic Amino Acid Is Crucial for Signaling between the Membrane-Spanning and Nucleotide-Binding Domains of Multidrug Resistance Protein 1 (MRP1; ABCC1). NBDs
12  2018 Development of Novel Intramolecular FRET-Based ABC Transporter Biosensors to Identify New Substrates and Modulators. FRET, GFP, HIV, RFP
13  2018 Endogenous Stimuli-Responsive Nucleus-Targeted Nanocarrier for Intracellular mRNA Imaging and Drug Delivery. DOX, DS, mRS
14  2018 Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae. iNKT cells
15  2018 Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth. NF-kappaB, TNBC
16  2018 Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells. HMM, MDR
17  2018 Reversal Effects of Bound Polyphenol from Foxtail Millet Bran on Multidrug Resistance in Human HCT-8/Fu Colorectal Cancer Cell. 5-FU, BCRP, BPIS, MW, P-gp, Rh-123, RT-PCR, VCR
18  2018 S100A9 regulates cisplatin chemosensitivity of squamous cervical cancer cells and related mechanism. GST-pi, LRP, P-gp, S100A9
19  2018 Solanine reverses multidrug resistance in human myelogenous leukemia K562/ADM cells by downregulating MRP1 expression. ADR, JNK1, MDR
20  2018 Transcriptional activity of detoxification genes is altered by ultraviolet filters in Chironomus riparius. 4-MBC, BP-3, UV
21  2017 Acetazolamide Suppresses Multi-Drug Resistance-Related Protein 1 and P-Glycoprotein Expression by Inhibiting Aquaporins Expression in a Mesial Temporal Epilepsy Rat Model. AQP, MTLE, NS, P-gp
22  2017 Effect and mechanism of resveratrol on drug resistance in human bladder cancer cells. ADM, GST, LRP, MDR, RES
23  2017 Establishment and characterization of arsenic trioxide resistant KB/ATO cells. ATO, BCRP
24  2017 IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway. IDH1, NQO1, Nrf2
25  2017 MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion. ABC, CS, MDR
26  2017 Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells. ADM, LRP, MDR
27  2017 The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells. CML, lncRNA, MDR
28  2017 Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1. DOX, NSCLC
29  2017 [MiR-145 inhibits drug resistance to Oxaliplatin in colorectal cancer cells through regulating G protein coupled receptor 98]. GP, GPR98
30  2016 3D-QSAR AND CONTOUR MAP ANALYSIS OF TARIQUIDAR ANALOGUES AS MULTIDRUG RESISTANCE PROTEIN-1 (MRP1) INHIBITORS. 3D-QSAR, ABC, CoMFA, CoMSIA
31  2016 ABC transporters as mediators of drug resistance and contributors to cancer cell biology. ABC, BCRP, P-gp
32  2016 Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1. ESCC, MDR, mRNA, P-gp, qRT-PCR, WB
33  2016 Does the Clearance of Inhaled (99m)Tc-Sestamibi Correlate with Multidrug Resistance Protein 1 Expression in the Human Lung? P-gp
34  2016 Effect of CD38 on the multidrug resistance of human chronic myelogenous leukemia K562 cells to doxorubicin. ADP, CD, P-gp
35  2016 Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma. ESCC, HER2, OS, PFS
36  2016 Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers. DOX, NSCLCs, P-gp
37  2016 Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line. Bcl-2, ERCC1, MDR1, miR-196a, miR-NC, NSCLC, qRT-PCR
38  2016 Mechanism study of PEGylated polyester and beta-cyclodextrin integrated micelles on drug resistance reversal in MRP1-overexpressed HL60/ADR cells. beta-CD, PCL, PEG, PLA
39  2016 Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression. OS, siRNA
40  2016 P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load. P-gp
41  2016 Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance. ---
42  2016 Quercetin affects glutathione levels and redox ratio in human aortic endothelial cells not through oxidation but formation and cellular export of quercetin-glutathione conjugates and upregulation of glutamate-cysteine ligase. GCL, HAEC, LPS
43  2016 The role of PGC-1alpha and MRP1 in lead-induced mitochondrial toxicity in testicular Sertoli cells. PGC-1alpha
44  2015 ATP-Binding Cassette Transporter Structure Changes Detected by Intramolecular Fluorescence Energy Transfer for High-Throughput Screening. FRET, GFP
45  2015 Cellular and regional specific changes in multidrug efflux transporter expression during recovery of vasogenic edema in the rat hippocampus and piriform cortex. BCRP, MRP4, p-gp, PC, SE
46  2015 Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids. GSTM1, MM, VAs, VCR, VDS, VRB
47  2015 Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells. CSCs, GST-pi, LRP, NSCLC
48  2015 Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. 5-FU, CCA, CDK1, FAK, GEM, MMP-9, NF-kappaB, PKC, RT-PCR, uPA
49  2015 Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance. 5-FU, MDR, NIR
50  2015 Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme. BBB, GBM, MRP4
51  2015 Integrin-Linked Kinase, Snail and Multidrug Resistance Protein 1: Three concordant players in the progression of non-small cell lung cancer. ILK, LN, NSCLC
52  2015 Myeloid differentiation factor 88 promotes cisplatin chemoresistance in ovarian cancer. CCK-8, MyD88, OC, siRNA, XIAP
53  2015 Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity. ---
54  2015 Prion protein regulates glutathione metabolism and neural glutamate and cysteine uptake via excitatory amino acid transporter 3. EAAT3, gamma-GT, GGT, PrP
55  2014 A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. DOX, ECM, HA, LRP, MDR, NP, PCa, PCL, PEG
56  2014 Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux. ---
57  2014 Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival. CRC, NQO1, Nrf2
58  2014 Differential functional rescue of Lys(513) and Lys(516) processing mutants of MRP1 (ABCC1) by chemical chaperones reveals different domain-domain interactions of the transporter. HEK, PEG, TM9
59  2014 Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1). ---
60  2014 FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1. DOX, P-gp
61  2014 Glutathione depletion regulates both extrinsic and intrinsic apoptotic signaling cascades independent from multidrug resistance protein 1. ---
62  2014 Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors. ABC, GPR55, LPI
63  2014 Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter. ABC
64  2014 Multidrug resistance protein 1 localization in lipid raft domains and prostasomes in prostate cancer cell lines. ---
65  2014 Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells. Bax, Bcl-xL, HCC, MDR, P-gp, TS
66  2014 Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future. ---
67  2014 The accumulation and efflux of lead partly depend on ATP-dependent efflux pump-multidrug resistance protein 1 and glutathione in testis Sertoli cells. ---
68  2014 Triggering of protection mechanism against Phoneutria nigriventer spider venom in the brain. PNV
69  2013 (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP. ABC, BBB, BCRP, P-gp, PET
70  2013 Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4. CGPs, MRPs
71  2013 Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells. ---
72  2013 Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. ABC, BCRP, MDR, P-gp
73  2013 Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. BC, BCRP, CTC, PCT
74  2013 Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients. ---
75  2013 Study of the mechanisms underlying the reversal of multidrug resistance of human neuroblastoma multidrug-resistant cell line SK-N-SH/MDR1 by low-intensity pulsed ultrasound. GST-pi, LIPUS, MDR, P-gp, SEM
76  2013 The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. ABC, BBB, BCRP, CNS, Mdr1a, Mdr1b
77  2013 Two polymorphic variants of ABCC1 selectively alter drug resistance and inhibitor sensitivity of the multidrug and organic anion transporter multidrug resistance protein 1. HEK, nsSNPs
78  2013 [Tetrandrine reversed the resistance of tamoxifen in human breast cancer MCF-7/TAM cells: an experimental research]. Tet
79  2012 Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line. 5-FU, E-cad, HCC, MDR, P-gp, TS
80  2012 Current status on marine products with reversal effect on cancer multidrug resistance. ABC, BCRP, MDR, P-gp
81  2012 Effect of multiple cysteine substitutions on the functionality of human multidrug resistance protein 1 expressed in human embryonic kidney 293 cells: identification of residues essential for function. ABC, MSD
82  2012 Formaldehyde induces rapid glutathione export from viable oligodendroglial OLN-93 cells. ---
83  2012 Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells. FL-mHtt, gamma-GT, GCL, GPx, GRed, GS, GST, HD, HTT, ROS
84  2012 Glutathione-mediated neuroprotection against methylmercury neurotoxicity in cortical culture is dependent on MRP1. CHX, DCF, GSHME, ROS
85  2012 Increased expression and function of P-glycoprotein in peripheral blood CD56+ cells is associated with the chemoresistance of non-small-cell lung cancer. NSCLC, P-gp
86  2012 Induction of DNA strand breaks is critical to predict the cytotoxicity of gemtuzumab ozogamicin against leukemic cells. GO, P-gp
87  2012 Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system. GST, MDR, P-gp, SFN
88  2012 Multidrug resistance reversal effects of aminated thioxanthones and interaction with cytochrome P450 3A4. BCRP, CYP3A4, MDR, P-gp
89  2012 Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1alpha/P-gp and MRP1 signaling pathway in vitro and in vivo. ADR, MDR, P-gp, pHi, PPZ, V-ATPases
90  2012 Spatiotemporally controlled single cell sonoporation. ---
91  2012 The expression and significance of MRP1, LRP, TOPOIIbeta, and BCL2 in tongue squamous cell carcinoma. Bcl-2, LRP, TopoIIbeta
92  2012 The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. BCRP, P-gp, THP
93  2011 2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance. P-gp
94  2011 Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy? BCRP, LRP, MDR, mRNA, NSCLC, PCR
95  2011 Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines. 5-FU, MDR1, MRP2, MRP3
96  2011 Enhanced glutathione depletion, protein adduct formation, and cytotoxicity following exposure to 4-hydroxy-2-nonenal (HNE) in cells expressing human multidrug resistance protein-1 (MRP1) together with human glutathione S-transferase-M1 (GSTM1). GSTM1, GSTs, HNE
97  2011 Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2. CLs
98  2011 Expressions of topoisomerase IIalpha and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients. BCRP, LRP, NSCLC, P-gp, SCLC, Top IIalpha
99  2011 Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1. ABC
100  2011 Molecular docking studies and in vitro screening of new dihydropyridine derivatives as human MRP1 inhibitors. DHP, MDR